Population survey to determine risk factors for Mycobacterium leprae transmission and infection

International Journal of Epidemiology

Volumn 33, Issue 6, 2004, Pages 1329-1336

  Bakker, Mirjam I ^a   Hatta, Mochammad ^b   Kwenang, Agnes ^b   Faber, William R ^c   van Beers, Stella M ^a   Klatser, Paul R ^a   Oskam, Linda ^a  

^a ROYAL TROPICAL INSTITUTE   (Netherlands)

^b HASANUDDIN UNIVERSITY   (Indonesia)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Epidemiology; Geographic information system; Leprosy; Mycobacterium leprae; Serology

Indexed keywords

BACTERIUM ANTIBODY;

DISEASE PREVALENCE; DISEASE TRANSMISSION; GIS; LEPROSY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL TRANSMISSION; BLOOD SAMPLING; CHILD; CLINICAL EXAMINATION; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISCRIMINANT ANALYSIS; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC INFORMATION SYSTEM; HUMAN; INDONESIA; INFECTION RISK; LEPROSY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM LEPRAE; POPULATION RESEARCH; PRIORITY JOURNAL; SERODIAGNOSIS; SEROPREVALENCE; SEX DIFFERENCE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH SURVEYS; HUMANS; INDONESIA; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; SOCIAL ENVIRONMENT;

ASIA; EASTERN HEMISPHERE; EURASIA; INDONESIA; SOUTHEAST ASIA; WORLD;

EID: 12344260683     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh266     Document Type: Article

References (32)

1. World Health Organization. The Final Push Towards Elimination of Leprosy, Strategic Plan 2000-2005. Geneva: World Health Organization, 2000.
2. World Health Organization. Leprosy - Global situation. Wkly Epidemiol Rec 2002;1:1-2.
3. Lockwood DNJ. Leprosy elimination - a virtual phenomenon or a reality? BMJ 2002;324:1516-18.
4. Van Beers SM, Hatta M, Klatser PR. Patient contact is the major determinant in incident leprosy: implication for future control. Int J Lepr Other Mycobact Dis 1999;67:119-28.
5. Anonymous. Report of the International Leprosy Association Technical Forum. Paris, France, 22-28 February 2002. Int J Lepr Other Mycobact Dis 2002;70:S1-S62.
6. Fine PEM, Sterne JAC, Pönnighaus JM et al. Household and dwelling contact as risk factor leprosy in Northern Malawi. Am J Epidemiol 1997;146:91-102.
7. Roche PW, Britton WJ, Failbus SS, Williams D, Pradhan HM, Theuvenet WJ. Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates on antibody responses. Int J Lepr Other Mycobact Dis 1990; 58: 80-90.
8. Cunanan A, Chan GP, Douglas JT. Risk of development of leprosy among culion contacts. Int J Lepr Other Mycobact Dis 1998;66:78A.
9. Cellona RV, Walsh GP, Fajardo TT et al. Cross-sectional assessment of ELISA reactivitity in leprosy patients, contacts and normal population using the semisynthetic antigen natural disaccharide octyl bovine serum albumin (ND-O-BSA) in Cebu, The Philippines. Int J Lepr Other Mycobact Dis 1993;61:192-98.
10. Gonzalez-Abreu E, Mora N, Perez M, Pereira M, Perez J, Gonzalez AB. Serodiagnosis of leprosy in patients' contacts by enzyme-linked immunosorbent assay. Lepr Rev 1990;61:145-50.
11. Hatta M, van Beers SM, Madjid B, Djumadi A, de Wit MYL, Klatser PR. Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia. Trans R Soc Trop Med Hyg 1995;89:381-85.
12. Chanteau S, Cartel JL, Roux J, Plichart R, Bach MA. Comparison of synthetic antigens for detecting antibodies to phenolic glycolipid I in patients with leprosy and their household contacts. J Infect Dis 1988;157:770-76.
13. Van Beers SM, Izumi S, Madjid B, Maeda Y, Day R, Matser PR. An epidemiological study of leprosy infection by serology and polymerase chain reaction. Int J Lepr Other Mycobact Dis 1994;62:1-9.
14. Bagshawe AF, Garsia RJ, Baumgart K, Astbury L. IgM serum antibodies to phenolic glycolipid-I and clinical leprosy: two years' observation in a community with hyperendemic leprosy. Int J Lepr Other Mycobact Dis 1990;58:25-30.
15. Clarke KC, McLafferty SL, Tempalski BJ. On epidemiology and geographic information systems: a review and discussion of future directions. Emerg Infect Dis 1996;2:85-92.
16. Bakker MI, Hatta M, Kwenang A, Klatser PR, Oskam L. Epidemiology of leprosy of five isolated islands in the Flores Sea, Indonesia. Trop Med Int Health 2002;7:780-87.
17. World Health Organization. WHO Expert Committee on leprosy. WHO Technical Report Series 1998;874:1-43.
18. Bührer-Sekula S, Sarno EN, Oskam L et al. We of ML dipstick as a tool to classify leprosy patients. Int J Lepr Other Mycobact Dis 2000;68:456-63.
19. Kulldorff M, Nagarwalla N. Spatial disease dusters: detection and inference. Stat Med 1995;14:799-810.
20. Bührer SS, Smits HL, Gussenhoven GC, van Ingen CW, Klatser PR. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae. Am J Trop Med Hyg 1998; 58: 33-36.
21. Hussain R, Jamil S, Kifayet A et al. Quantitation of IgM antibodies to the M. leprae synthetic dissacharide can predict early bacterial multiplication in leprosy. Int J Lepr Other Mycobact Dis 1990;58:491-502.
22. Saad MHF, Medeiros MA, Gallo MEN, Gontijo PP, Fonseca LS. IgM immunoglobulins reacting with the phenolic glycolipid-1 antigen from mycobacterium leprae in sera of leprosy patients and their contacts. Mem Inst Oswaldo Cruz 1990;85:191-94.
23. Van Beers S, Hatta M and Klatser PR. Seroprevalence rates of antibodies to phenolic glycolipid-I among school children as an indicator of leprosy endemicity. Int J Lepr Other Mycobact Dis 1999; 67: 43-49.
24. Fitness J, Tosh K, Hill AV. Genetics of susceptibility to leprosy. Genes Immun 2002;3:441-53.
25. Ponnighaus JM, Fine PEM, Sterne JAC, Malema SS, Bliss L, Wilson RJ. Extended schooling and good housing conditions are associated with reduced risk of leprosy in rural Malawi. Int J Lepr Other Mycobact Dis 1994;62:345-52.
26. Menzel S, Harboe M, Bergsvik H, Brennan PJ. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy. Int J Lepr Other Mycobact Dis 1987;55:617-25.
27. Fine PEM, Ponnighaus JM, Burgess P, Clarkson JA, Draper CC. Seroepidemiological studies of leprosy in Northern Malawi based on an Enzyme-linked Immunosorbent Assay using synthetic glycoconjugate antigen. Int J Lepr Other Mycobact Dis 1988;56:243-54.
28. Soebono H, Klatser PR. A seroepidemiological study of leprosy in high- and low-endemic Indonesian villages. Int J Lepr Other Mycobact Dis 1991;59:416-25.
29. Agis F, Schlich P, Cartel JL, Guidi C, Bach MA. Use of anti-M leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy. Int J Lepr Other Mycobact Dis 1988;56:527-36.
30. Douglas JT, Hirsch DS, Fajardo TT et al. Evaluation of Mycobacterium leprae antigens in the serological monitoring of a clofazimine-based chemotherapy study of dapsone resistant lepromatous leprosy patients in Cebu, Philippines. Lepr Rev 1989; 60:8-19.
31. Klatser PR, de Wit MYL, Fajardo TT et al. Evaluation of Mycobacterium leprae antigens in the monitoring of a dapsone-based chemotherapy of previously untreated lepromatous patients in Cebu, Philippines. Lepr Rev 1989;60:178-86.
32. Buhrer-Sekula S, Smits HL, Gussenhoven GC et al. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol 2003;41:1991-95.